Current language:
- HR Hrvatski
The translation of this page has been generated by machine translation.
Machine translations can contain errors potentially reducing clarity and accuracy; the Ombudsman accepts no liability for any discrepancies. For the most reliable information and legal certainty, please refer to the source version in English linked above.
For more information please consult our language and translation policy.
Machine translations can contain errors potentially reducing clarity and accuracy; the Ombudsman accepts no liability for any discrepancies. For the most reliable information and legal certainty, please refer to the source version in English linked above.
For more information please consult our language and translation policy.
Odgovor Europske komisije na Preporuku Europskog ombudsmana o odbijanju Europske komisije za javni pristup tekstualnim porukama koje su razmijenili predsjednik Komisije i glavni izvršni direktor farmaceutskog poduzeća o kupnji bolesti COVID-19
Correspondence - Date Monday | 27 June 2022
Case 1316/2021/MIG - Opened on Thursday | 16 September 2021 - Recommendation on Wednesday | 26 January 2022 - Decision on Tuesday | 12 July 2022 - Institution concerned European Commission ( Maladministration found ) - Country Austria
Preuzmite priloženi pdf dokument.